Longboard Pharmaceuticals Inc (LBPH)
21.38
-1.44
(-6.29%)
USD |
NASDAQ |
May 03, 16:00
21.37
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals Price to Book Value: 18.81 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 18.81 |
May 02, 2024 | 20.08 |
May 01, 2024 | 19.33 |
April 30, 2024 | 18.75 |
April 29, 2024 | 18.68 |
April 26, 2024 | 17.36 |
April 25, 2024 | 16.94 |
April 24, 2024 | 17.38 |
April 23, 2024 | 17.84 |
April 22, 2024 | 16.43 |
April 19, 2024 | 15.35 |
April 18, 2024 | 15.85 |
April 17, 2024 | 14.96 |
April 16, 2024 | 16.06 |
April 15, 2024 | 16.06 |
April 12, 2024 | 16.90 |
April 11, 2024 | 18.00 |
April 10, 2024 | 16.12 |
April 09, 2024 | 16.35 |
April 08, 2024 | 16.00 |
April 05, 2024 | 15.88 |
April 04, 2024 | 16.27 |
April 03, 2024 | 15.95 |
April 02, 2024 | 17.41 |
April 01, 2024 | 18.53 |
Date | Value |
---|---|
March 28, 2024 | 19.01 |
March 27, 2024 | 18.46 |
March 26, 2024 | 17.70 |
March 25, 2024 | 17.46 |
March 22, 2024 | 17.58 |
March 21, 2024 | 17.58 |
March 20, 2024 | 18.10 |
March 19, 2024 | 18.13 |
March 18, 2024 | 18.02 |
March 15, 2024 | 17.00 |
March 14, 2024 | 16.63 |
March 13, 2024 | 17.57 |
March 12, 2024 | 16.72 |
March 11, 2024 | 17.30 |
March 08, 2024 | 17.30 |
March 07, 2024 | 17.66 |
March 06, 2024 | 17.44 |
March 05, 2024 | 17.67 |
March 04, 2024 | 18.55 |
March 01, 2024 | 18.44 |
February 29, 2024 | 19.16 |
February 28, 2024 | 20.68 |
February 27, 2024 | 20.22 |
February 26, 2024 | 19.85 |
February 23, 2024 | 19.41 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5429
Minimum
Jun 24 2022
22.52
Maximum
Jan 23 2024
3.292
Average
1.341
Median
Apr 27 2021
Price to Book Value Benchmarks
CEL-SCI Corp | 6.955 |
AIM ImmunoTech Inc | 2.116 |
IGC Pharma Inc | 3.599 |
NovaBay Pharmaceuticals Inc | 2.094 |
Protalix BioTherapeutics Inc | 2.481 |
Price to Book Value Related Metrics
Price | 21.38 |
Earnings Yield | -11.14% |
Market Cap | 769.87M |